Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lleo

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|May 21, 2014
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsAna Lleo, Weici Zhang, W Hayes McDonald, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 24, 2026
Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the LiverClara Balsano, Anna Alisi, Patrizia Burra, et al.
Plos One|June 20, 2020
Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinomaEzio Lanza, Chiara Masetti, Gaia Messana, et al.
Hepatology (Baltimore, Md.)|June 23, 2010
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosisAna Lleo, Christopher L Bowlus, Guo-Xiang Yang, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisQinglong Jin, Yuki Moritoki, Ana Lleo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2020
Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligenceSilvia Giordano, Sen Takeda, Matteo Donadon, et al.
Cancers|April 30, 2021
Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral CenterAna Lleo, Francesca Colapietro, Patrick Maisonneuve, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosisAna Lleo, Jieyue Liao, Pietro Invernizzi, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicineMichela Anna Polidoro, Erika Ferrari, Cristiana Soldani, et al.
Plos One|October 28, 2020
Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinomaEzio Lanza, Chiara Masetti, Gaia Messana, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|May 21, 2014
Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cellsAna Lleo, Weici Zhang, W Hayes McDonald, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 24, 2026
Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the LiverClara Balsano, Anna Alisi, Patrizia Burra, et al.
Plos One|June 20, 2020
Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinomaEzio Lanza, Chiara Masetti, Gaia Messana, et al.
Hepatology (Baltimore, Md.)|June 23, 2010
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosisAna Lleo, Christopher L Bowlus, Guo-Xiang Yang, et al.
Hepatology (Baltimore, Md.)|December 3, 2011
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisQinglong Jin, Yuki Moritoki, Ana Lleo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2020
Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligenceSilvia Giordano, Sen Takeda, Matteo Donadon, et al.
Cancers|April 30, 2021
Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral CenterAna Lleo, Francesca Colapietro, Patrick Maisonneuve, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosisAna Lleo, Jieyue Liao, Pietro Invernizzi, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicineMichela Anna Polidoro, Erika Ferrari, Cristiana Soldani, et al.
Plos One|October 28, 2020
Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinomaEzio Lanza, Chiara Masetti, Gaia Messana, et al.
Pageof 21